- Home
- FERG vs ONC Comparison
FERG vs ONC Comparison
Compare FERG & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FERG
- ONC
- Stock Information
- Founded
- FERG 1887
- ONC 2010
- Country
- FERG United States
- ONC Switzerland
- Employees
- FERG 36000
- ONC N/A
- Industry
- FERG Miscellaneous
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- FERG Miscellaneous
- ONC Health Care
- Exchange
- FERG Nasdaq
- ONC Nasdaq
- Market Cap
- FERG 46.5B
- ONC 37.3B
- IPO Year
- FERG N/A
- ONC N/A
- Fundamental
- Price
- FERG $233.51
- ONC $343.28
- Analyst Decision
- FERG Buy
- ONC Strong Buy
- Analyst Count
- FERG 14
- ONC 10
- Target Price
- FERG $237.50
- ONC $340.70
- AVG Volume (30 Days)
- FERG 2.5M
- ONC 297.4K
- Earning Date
- FERG 09-16-2025
- ONC 11-11-2025
- Dividend Yield
- FERG 1.43%
- ONC N/A
- EPS Growth
- FERG 9.31
- ONC N/A
- EPS
- FERG 9.32
- ONC N/A
- Revenue
- FERG $30,762,000,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- FERG $7.08
- ONC $896.81
- Revenue Next Year
- FERG $6.04
- ONC N/A
- P/E Ratio
- FERG $24.85
- ONC N/A
- Revenue Growth
- FERG 3.80
- ONC 47.33
- 52 Week Low
- FERG $146.00
- ONC $170.99
- 52 Week High
- FERG $243.40
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- FERG 56.28
- ONC 57.47
- Support Level
- FERG $223.17
- ONC $334.53
- Resistance Level
- FERG $226.55
- ONC $355.30
- Average True Range (ATR)
- FERG 4.30
- ONC 7.30
- MACD
- FERG 0.57
- ONC 0.05
- Stochastic Oscillator
- FERG 70.00
- ONC 64.05
About FERG Ferguson plc
Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.